SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-036635
Filing Date
2020-06-15
Accepted
2020-06-15 16:42:23
Documents
2
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2162
2 POA DOCUMENT poa.txt EX-24.3_922307 4234
  Complete submission text file 0001209191-20-036635.txt   7746
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 87 CAMBRIDGEPARK DRIVE C/O RA PHARMACEUTICALS, INC. CAMBRIDGE MA 02140
Business Address
Treco Douglas A (Reporting) CIK: 0001688192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 20963900